Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK of Ciprofol in Hypoproteinemia
NCT06425757Phase 4Completed
- Start
- Apr 2024
- Primary completion
- Apr 2025
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 4, open-label trial of ciprofol in general anesthesia (3 arms). Primary endpoint: Blood concentrations of Ciprofol at 4 hours. Started Apr 2024; status: completed.
02
Drugs
ciprofol
03
Conditions
general anesthesia
Beyond the preview
Go deeper on NCT06425757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06425757.